ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Ono Pharmaceutical Co. Ltd clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 157 studies whose lead sponsor is Ono Pharmaceutical Co. Ltd or one of 2 companies grouped under it. 25 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 12, 2026.

Our grouping of 4 registry names, not the registry’s. See them and correct one ↓

Compare Ono Pharmaceutical with Bristol-Myers Squibb and Jiangsu HengRui Medicine →

Pipeline: 16 programs

Each counted once: 16 with a study Ono Pharmaceutical Co. Ltd leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 5 of 7 with the most live studies.

Program
vimseltinibPhase 3 · 5 live · Synovitis, Pigmented Villonodular · primary completion Dec 2026☆ Track
NivolumabPhase 3 · 4 live · Carcinoma, Non-Small-Cell Lung · primary completion Dec 2027☆ Track
BMS-986310Phase 3 · 4 live · Stomach Neoplasms · primary completion Feb 2028☆ Track
tirabrutinibPhase 3 · 4 live · Leukemia, Lymphocytic, Chronic, B-Cell · primary completion Sep 2027☆ Track
ripretinibPhase 3 · 3 live · Gastrointestinal Stromal Tumors · primary completion Dec 2027☆ Track

2 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Ono Pharmaceutical Co. Ltd’s own registered studies; Ono Pharmaceutical Co. Ltd’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Ono Pharmaceutical Co. Ltd’s studies test, most open studies first — 39 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 39; every drug is on its own page, and each page lists its sponsors.

Coming up

12 of Ono Pharmaceutical Co. Ltd’s studies under way reach primary completion within a year, 2 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 2D
  3. 2J’27
  4. F
  5. 1M
  6. A
  7. M
  8. 1J
  9. J
  10. 1A
  11. 3S
  12. 1O
  13. 1N

All 12

Show 7 more

Add all 12 to your calendar (.ics) → With an account.

All 157 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now2516%Recruiting 21 · Not yet recruiting 4
  • Under way, not recruiting2013%
  • Completed9460%
  • Stopped early1711%Terminated 16 · Withdrawn 1
  • Status unknown or other11%

Phase

  • Phase 174
  • Phase 258
  • Phase 333
  • Phase 41

Where

  • Japan70
  • United States57
  • United Kingdom22
  • Korea, Republic of14
  • Taiwan13
  • Netherlands12

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 1625
  20. 1326

By the year each study started; 22 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Ono Pharmaceutical Co. Ltd.

  • Ono Pharmaceutical Co. Ltd
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    63 studies
  • Ono Pharmaceutical Co., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    49 studies
  • Deciphera Pharmaceuticals, LLC
    Acquired — became part of Ono Pharmaceutical Co. Ltd, Jun 11, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    24 studies →
  • Ono Pharma USA Inc
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    21 studies →

Focus areas

Conditions Ono Pharmaceutical Co. Ltd leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 157. Browse all 157 →